“Digital pathology is gaining widespread adoption for medical education and training. The release of VENTANA Vector software expands our Digital Pathology portfolio to address the growing needs of the pathology education market. The software will make pathology training more accurate and cost-effective, while empowering students with collaborative learning strategies,” said Vikram Mohan International Business Leader, Digital Pathology, Ventana Medical Systems, Inc.
Not surprising, many medical schools are abandoning the light microscope as the primary teaching tool in pathology. VENTANA Vector software can help standardize training content by enabling students to view high quality, consistent slide images, and eliminate the frustration of having to share limited resources such as slide sets and multi-head microscopes.
“Now we can pick the best slides, scan them and use the same digital slide set for all students. They can all access the same teaching materials anytime from their computer, tablet or smart phone.” Dr. Sung Professor of Pathology, Women & Infants Hospital Providence Rhode Island
The VENTANA Vector software platform is unique in the digital pathology market in offering a fully customizable interface, ability for users to view on mobile devices with both Cloud and local hosting options and is fully compatible with iScan Coreo and VENTANA iScan HT slide scanners.
About Ventana Medical Systems, Inc.Ventana Medical Systems, Inc. (“VMSI”) (six:RO)(six:ROG)(otcqx:RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA products are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to help reduce errors, support diagnosis and enable informed treatment decisions by anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies.
Visit www.ventana.com to learn more.
VENTANA, the VENTANA logo, iScan and VENTANA iScan are trademarks of Roche.
Source: Ventana Medical Systems, Inc.
